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Abstract: Silver nanoparticles (AgNPs) have recently become very attractive for the scientific
community due to their broad spectrum of applications in the biomedical field. The main advantages
of AgNPs include a simple method of synthesis, a simple way to change their morphology and high
surface area to volume ratio. Much research has been carried out over the years to evaluate their
possible effectivity against microbial organisms. The most important factors which influence the
effectivity of AgNPs against microorganisms are the method of their preparation and the type of
application. When incorporated into fabric wound dressings and other textiles, AgNPs have shown
significant antibacterial activity against both Gram-positive and Gram-negative bacteria and inhibited
biofilm formation. In this review, the different routes of synthesizing AgNPs with controlled size and
geometry including chemical, green, irradiation and thermal synthesis, as well as the different types
of application of AgNPs for wound dressings such as membrane immobilization, topical application,
preparation of nanofibers and hydrogels, and the mechanism behind their antimicrobial activity,
have been discussed elaborately.
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1. Introduction
Infected wounds represent a complex, non-trivial, problem which seriously jeopardizes the
health and life of patients. One of the most frequent problems is a chronic ulcer with deep tissue
damage in patients with diabetes, connected with abnormal fibroblast and keratinocyte proliferation,
reduced cell migration and decreased angiogenesis, which can lead to impairment of vascularization,
delayed wound contraction and subsequent formation of non-healing diabetic wounds [1]. Not only
diabetic wounds but also leg ulcers, arterial insufficiency, pressure ulcers and burns impose substantial
morbidity and mortality, deeply affecting quality of life, with high economic burden [2]. Generally,
wounds can be divided into acute and chronic [3]. When chronic wounds were analyzed in a mouse
model, a huge diversity of microorganisms formatting biofilm (for example, Enterobacter cloacae,
Streptococcus thermophilus, Propionibacterium acnes) and without biofilm formation (Achromobacter
xylosoxidans) were observed. Biofilms as sessile microbial consortia established in a three-dimensional
structure are an important strategy implemented by microorganisms to survive in sometimes harsh
environmental conditions [4]. Biofilms within the in vitro environment only are often referred to as
immature when they have been growing for less than 24 h and mature when they have been growing
for more than 24 h [5]. The ratio between different biofilm and non-biofilm creating bacterial types
in a wound is dependent on type and time of treatment [6]. Thus, because a variety of different
bacterial species live in the wounds, there is a widely acknowledged need for new antibacterial
agents to address the global increase in resistance [7]. The level of resistance, especially against
traditional antibiotics (for example, methicillin-resistant Staphylococcus aureus [8], penicillin-resistant
Enterococcus faecalis [9] or multiresistant Mycobacterium tuberculosis [10]) is still increasing, and the
rising incidence of antimicrobial resistance among pathogenic bacteria is one of the greatest healthcare
challenges facing humanity today [11]. Thus, new approaches to overcome bacterial resistance
are being tried, comprising by using plant extracts [12] or a combination of antibiotics and other
antibacterial materials [13], especially nanomaterials, which comprise unary [14], binary (AgAu,
AgPt NPs) [15,16] or multicomponent materials (CdZnSe-CdZnS nanoalloy) [17]. Nanotechnology is
nowadays a flourishing scientific field, which associates nanoparticles with extraordinary functions
and size-dependent physicochemical properties, differing significantly from the macroscopic forms of
these elements. Nanomaterials comprise nanoparticles (NPs), which can be divided into inorganic and
organic nanoparticles and nanocomposites, which can be grouped into the porous material, colloids,
copolymers and gels. Finally, the applications of nanoparticles and nanocomposites in scaffolds and
coatings are via hydrogels, nanofibers and films (Figure 1). Over the years, inorganic nanoparticles
have been explored extensively in nanomedicine [18], electronics [19], drug delivery [20], biomedical
devices [21], food sectors as package material [22,23], and dentistry such as: prosthetic, restoration,
endodontic, orthodontic, periodontal and dental implant treatment. In addition, an improvement of
mechanical properties of dental materials; inhibition of adhesion and bacteria growth of Escherichia coli,
Streptococcus mutans, Enterococcus faecalis, Pseudomonas aeruginosa, S. aureus and the fungus Candida
albicanshave been observed [24], etc.
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Figure 1. Nanomaterials with potential use for wound treatment. Nanomaterials cover several groups 
of materials including nanoparticles, nanocomposites and different coatings and scaffolding 
materials. Nanoparticles can be divided into two groups depending on their chemical basis, which 
comprises inorganic (metal—Ag, Au, Zn, Cu etc.; non-metal—for example, Se) and organic 
(polymeric and non-polymeric) nanoparticles. From the perspective of nanocomposites, four groups 
can be recognized: porous materials, colloids, copolymers and gels. For the wound coating and 
scaffolds, hydrogels, nanofibers, films and membranes can be used. Adapted from [25] under a CC 
BY 4.0 license. 
Among the several inorganic NPs, silver NPs (AgNPs), due to their novel chemical, biological 
and physical properties as compared to their bulk form, have attracted the interest of researchers 
from the whole academic sphere. AgNPs have typical physical and chemical properties—for 
example, high thermal and electrical conductivity [26], surface-enhanced Raman scattering [27], 
chemical stability [28], catalytic activity [29] and non-linear optical behavior [30]. These properties 
take AgNPs to the top of the priority list, and they can be used in inks, in electronics and for medical 
purposes. Additionally, AgNPs are commonly known for their antibacterial, antifungal and antiviral 
properties. Mechanisms of effectivity comprise the disrupting of cell membranes, interaction with 
sulfhydryl groups of proteins, inactivation of respiratory enzymes, DNA modification, etc. (Figure 
2). Microorganisms, however, have also mechanisms to adapt and to resist to metals (for example, 
reduced uptake, through efflux, chemical modification of metals, etc.) [31]. 
Thus, there is a need for a better understanding of these parameters on the efficacy and toxicity 
of AgNPs. Wide variety in size, concentration, shape, materials, polymers and surfaces of AgNPs are 
commonly being used [32]. 
Figure 1. Nanomaterials with potential use for wound treatment. Nanomaterials cover several groups
of materials including nanoparticles, nanocomposites and different coatings and scaffolding materials.
Nanoparticles can be divided into two groups depending on their chemical basis, which comprises
inorganic (metal—Ag, Au, Zn, Cu etc.; non-metal—for example, Se) and organic (polymeric and
non-polymeric) nanoparticles. From the perspective of nanocomposites, four groups can be recognized:
porous materials, colloids, copolymers and gels. For the wound coating and scaffolds, hydrogels,
nanofibers, films and membranes can be used. Adapted from [25] under a CC BY 4.0 license.
Among the several inorganic NPs, silver NPs (AgNPs), due to their novel chemical, biological and
physical properti s as comp red to their bulk form, have attracted the interest of researchers
from the whole academic sphere. AgNPs have typical physical and chemical prop rties—for
exampl , high thermal and electrical conducti ity [26], surface-enhanced Raman scattering [27],
che ical stability [28], c talytic activity [29] and non-linear optical behavior [30]. These properties
take AgNPs to the top of the priority list, and they can be used in inks, in electronics and fo m dical
purposes. Additionally, AgNPs are commonly know for th ir antibacterial, antifungal and antiviral
ro erties. Mechanisms of effectivity comprise the disrupting of cell membranes, interaction with
sulfhydryl groups of proteins, inactivati n of r spiratory enzymes, DNA modification, tc. (Figure 2).
Microorganisms, however, have also mechanisms to adapt and to resist to metals (for exampl ,
reduced upt ke, through efflux, ch mical modification f metals, etc.) [31].
Thus, there is a need for a bett r understanding f these p rameters on the efficacy and toxicity of
AgNPs. Wid variety in size, conc ntration, shape, materials, polym r a d surfa es of AgNPs are
commonly being used [32].
The antimicrobial properties of AgNPs have been described and proven in various in vitro and
in vivo studies, and their applications in food packaging, soaps, cosmetics, fabrics and wound dressing
materials have also been reported [33]. There are a number of methods for antimicrobial susceptibility
testing (AST) of bacteria, which can be divided into diffusion methods and dilution methods [34,35].
The most used diffusion methods are the agar disk-diffusion method and antimicrobial gradient method
(Etest). The most used dilution methods are the broth dilution method and agar dilution method [36].
The broth dilution method can be further divided into the broth macrodilution method and broth
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microdilution method [36]. The broth macrodilution method has been standardized by the Clinical
and Laboratory Standards Institute (CLSI) for testing bacteria that grow aerobically [37]. The broth
microdilution method is standardized by CLSI for both anaerobic [38] and aerobic bacteria [39].
As a representative example of the agar plate disk diffusion test [40] and the broth microdilution
test (a measurement of growth curves) [41], our own experimental results for green-synthesized
nanoparticles are shown in Figure 3.Pharmaceutics 2020, 12, x 4 of 27 
 
 
Figure 2. Effect of silver nanoparticles (AgNPs) on the single bacterial cell. (A) AgNPs penetrate 
through the cell membrane and cause its disruption; intracellular metabolites are released via the 
disrupted membrane. (B) AgNPs release silver ions (Ag+) to generate reactive oxygen species (ROS) 
and induce oxidative stress. (C) ROS are, for example, responsible for lipid peroxidation, which 
significantly changes the distribution of intracellular and extracellular metabolites and causes a 
change in membrane permeability, because lipid strains are repulsed. Interaction of AgNPs and Ag+ 
with proteins can affect (D) DNA enzymatic replication machinery, (E) DNA transcription, (F) 
translation of DNA to polypeptide/protein chain on ribosomes (red-brown ovals), (G) proton efflux 
pumps, (H) electron transport chain (represented by blue, yellow and green ovals) and creation of 
energetic sources of cells (ATP). Adapted from [31], Copyright Springer Nature, 2013. 
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Figure 2. Effect of silver nanoparticles (AgNPs) on the single bacterial cell. (A) AgNPs penetrate
through the cell membrane and cause its disruption; intracellular metabolites are released via the
disrupted membrane. (B) AgNPs release silver ions (Ag+) to generate reactive oxygen species (ROS) and
induce oxidative stress. (C) ROS are, for example, responsible for lipid peroxidation, which significantly
changes the distribution of intracellular and extracellular metabolites and causes a change in membrane
permeability, because lipid strains are repulsed. Interaction of AgNPs and Ag+ with proteins can
affect (D) DNA enzymatic replication machinery, (E) DNA transcription, (F) translation of DNA to
polypeptide/protein chain on ribosomes (red-brown ovals), (G) proton efflux pumps, (H) electron
transport chain (represented by blue, yellow and green ovals) and creation of energetic sources of cells
(ATP). Adapted from [31], Copyright Springer Nature, 2013.
AgNPs are also used in water filter membranes for point-of-care water disinfection, utilizing their
antimicrobial properties [42]. The AgNPs can be used in all physical forms—for example, in colloidal
form (in enamel coating and paints), liquid form (cosmetics) and solid form (blended with polymer
scaffolds). For wounds, different types of treatment with silver and AgNPs were proposed and they
are shown in Figure 4. Application of nanomaterials on the wound can be direct, in the form of
powdered AgNPs or their solutions. The second possibility is the use of non-compact materials for
wound treatment as water-soluble polymers and hydrogels. The third possibility is the use of solid
polymers (fibers, membranes and films). The role of nanomaterial wound dressings in the wound
healing process, in general, is shown in Figure 5. One problematic aspect of AgNPs wound dressings
is that there are reported cases of bacterial resistance to AgNPs. For example, resistance to AgNPs
attributed to sil genes has been reported in clinical isolates of Klebsiella pneumoniae and Enterobacter
cloacae from burn cases [43]. Thus, the continuous development of a new combination of nanomaterials,
antibiotics, polymers, methods of incorporation and types of reduction of silver to obtain various
shapes of NPs is essentially necessary.
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Hydrogels and water-soluble polymers are being used as non-compact materials (they are easily 
rubbed on the skin); on the contrary, compact materials comprising fibers, membranes and films are 
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Figure 3. Two basic methods of screening of the antibacterial effect: (A) Effect of AgNPs in concentrations
of 5 (1), 2.5 (2), 1.25 (3) and 0.625 mg/mL (4) in the agar plate disk diffusion test on S. aureus cells after
24 h of incubation. Growth inhibition zones are marked by red circles. (B) The growth curve of S. aureus
without (control) or with 0.1 mg/ L AgNPs showed optical density of 620 nm (OD620), dependent on
the time of growth.
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Figure 4. Wound treatment with silver nanomaterials. Nanomaterials can be applied directly to the
wound (solution or powder nanoparticles) or nanomaterial-containing cloth and fabrics can be used.
Hydrogels and water-soluble polymers are being used as non-compact materials (they are easily rubbed
on the skin); on the contrary, compact materials comprising fibers, membranes and films are firm
and non-soluble.Pharmaceutics 2020, 12, x 6 of 27 
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the use of AgNPs. The articles were selected also upon impact factor (average impact factor is 6.31) 
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Figure 5. Summary of antimicrobial wound dressings with nanomaterials. The role of wound dressings
using nanomaterials in various phases of wound healing (which comprise inflammation, proliferation
and remodeling of the wound) is shown (the approximate duration of each phase is indicated in
parentheses). Mostly, the effect is achieved due to the physical protection of the wound, acceleration of
healing and broad antimicrobial action. Adapted from [25] under a CC BY 4.0 license.
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2. Methodology of the Review
The methodology of this review is summarized in Figure 6.
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Figure 6. Flowchart of choice of articles for review, “Silver Nanoparticles for Wound Dressing
Applications“. In the first phase, articles were searched according to the following keywords:
“silver nanoparticles in wounds”; “silver nanoparticles and therapeutic application”; “chemical synthesis
of AgNPs”; “green synthesis of AgNPs”; “irradiation synthesis of AgNPs”; “thermal synthesis of
AgNPs”. The following databases were used: Web of Science (WoS) core collection; PubMed and Embase,
searching since 2000. Completely, more than 11,000 articles were found (5809 WoS, 3018 PubMed and
2679 Embase). Condensate extraction of articles from this phase was used for writing introduction and
parts about the synthesis of particles. In the second phase, we were interested only in articles with the
keywords “AgNPs for wound dressing applications”. More than 600 articles were found (444 WoS,
83 PubMed and 140 Embase). Some of these articles were used for writing the main section concerning
different means of preparing AgNPs wound dressings. It is seen that using AgNPs, especially in wound
dressings, comprises the effort of many work teams from around the world; thus, it is impossible
to describe all techniques, materials and types of synthesis of AgNPs. We tried to choose several
representative examples for all types of synthesis and the most frequent using polymeric materials
to give the reader a complex view of the problematic nature of using AgNPs in wound dressing.
The articles which were preferred were articles from 2007, which describe mainly the use of AgNPs.
The articles were selected also upon impact factor (average impact factor is 6.31) and quartile of the
journal (Q1 and Q2). Finally, 129 articles were chosen to write this review.
This paper aims to summarize the various methods adopted for the synthesis of AgNPs that include
chemical, green, irradiation and thermal synthesis and routes of application of these nanoparticles
through membrane immobilization, topical application, nanofibers and hydrogel system for wound
dressing (see Figure 1). In this review paper, every aspect of AgNPs, from synthesis to their utilization
in wound dressing applications against various bacterial and fungal strains, has been discussed.
3. Synthesis of AgNPs
This review aims to conclude the newest findings of the antibacterial effect of AgNPs connected
with covering materials for wound dressing and healing. As mentioned above, four types of AgNPs
synthesis are described, namely chemical, green, irradiation and thermal. In this section, the basic
characteristics of each type of synthesis are briefly described. In chemical synthesis, the Turkevich
method and Brust–Schiffrin synthesis are mainly used [43]. The Turkevich method is based on the
reduction of the boiling solution of silver salt with a solution of citrate salt. The Brust–Schiffrin method
is mainly used for golden nanoparticles, but applications for other metals were also described [44].
Stabilization of AgNPs synthesis is ensured by using surfactants (thiols, amines, acids and alcohols)
or polymers (poly(vinyl alcohol), poly(vinylpyrrolidone), poly(ethylene glycol), poly(methacrylic
Pharmaceutics 2020, 12, 821 7 of 24
acid) and polymethyl methacrylate) [45]. Green synthesis represents a low-cost, environmentally
friendly way of producing AgNPs without using high temperatures and pressures [46]. Typically,
the plant [46–50], fungus [51–53] or bacteria extract is mixed with silver ions containing salt (silver
nitrate is mainly used [46–53]) and bioactive molecules of extracts reduce silver ions to elementary
silver. A huge advantage of using plant extracts is the fact that many plants contain health-beneficial
compounds, also known from their use in conventional medicine (for example, paclitaxel, vincristine
or artemisinin) [54]. After nucleation, the AgNPs can be precipitated with alcohol [55] (for example,
methanol, ethanol or isopropyl alcohol). Model synthesis is shown in Figure 7.
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Figure 7. The process of preparation of AgNPs. (A) A plant/fungus is (B) homogenized, extracted,
centrifugated and filtrated; subsequently (C), silver ions in the form of 0.1 M AgNO3 are added in a
1:1 (v/v) ratio. (D) AgNPs are formed within 24 h. (E) AgNPs are precipitated with methanol in a 1:1
(v/v) ratio for 1 h. (F) The solution of AgNPs is centrifuged for 15 min, 4000 g. (G)The supernatant is
discarded and AgNPs are dried by lyophilization for 24 h.
The process of reduction of Ag+ to Ag0 with biomolecules relates to the high reduction power of
the biomolecule cocktail. Depending on the extract composition, the velocity of stirring and time of
nucleation of AgNPs, AgNPs with different shapes can be obtained (Figure 8).
Irradiation synthesis [56–58] is connected with radiation of precursors or intermediate products of
reaction with electromagnetic radiation with different wavelengths. Only specialized laboratories with
a suitable radiation source and in respect to the difficult legislature can achieve this type of synthesis.
Jia et al. [56] prepared gold nanoclusters using triple helix glucan Lentiman via microwave-assisted
synthesis and subsequently employed them as seeds for Ag-Au nanoparticle alloy; these nanoparticles
increase in size with higher Ag amounts [56]. Mixed cellulose nanofibrils and AgNPs composites were
prepared by UV radiation [57]. Graphene oxide (GO)-supported AgNPs nanocomposite was prepared
via polyvinyl-pyrrolidone (PVP) and isopropanol (IPA)-assisted gamma irradiation [58].
Thermal synthesis is based on a thermal reduction of silver salt. A representative example
is the thermal reduction of AgNO3 [59] in an environment of poly(N-isopropylacryamide-co-2
-acrylamido-2-methylpropane sulfonic acid) (NIPAMSA) to form the hybrid hydrogels with
incorporated AgNPs.
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Figure 8. A model example of green synthesis of AgNPs. As mentioned in Figure 7, the green synthesis
of AgNPs is based on using extracts from plants or fungi, which contain a giant spectrum of different
oxidative and reductive agents. These molecules reduce silver ions (Ag+) to elementary silver (Ag0).
Compounds which influence the reduction and capping of originating AgNPs are, for example, proteins,
alkaloids or polysaccharides. Different types of nanoparticles can be prepared depending on reaction
conditions (metal concentration, extract concentration, length of synthesis, stabilization agents, etc.).
4. AgNPs Immobilization into Membrane and Composite Material
Membrane and composite material-immob lized n n particl s can have a plethor of different
functions (e.g., disinfection, catalytic activity). An example which can be mentioned as a c mp site
material created by Liang et al. is a material bas d on a pre-treated eg -shell membr ne with procyanidin
to reduce s lver ions into n noparticles in orpo ated into th membrane structure. This membrane
had catalytic act vity consisting of the conversion of 4-nitrophenol to 4-aminophenol [60]. Silver ions
reduced with ascorbic acid formed nanoparticles i corporated into poly thersulfone membrane
and showed antibact ri l activity against S. aureus, S. albus a d E. coli when tested on bacterial
plates [61]. Hanif et al. [62] used a non-toxic and env ronmentally friendly method based on tannic
acid- ediated silver salt layer-by-layer in-situ reductions. This method was used for the preparation
of a cellulose-AgNPs composite wit uniform and contro led ize and distribu on of AgNP for
point-of-use water disinfection, which was tested successfu ly on E. coli bacte ia. In the study published
by Dong et al. [63], casein-coated AgNPs were embedd d into acetate-c lulose membrane for control
of biofouling. AgNPs effectively suppressed the growth of Serratia marcescens, and specifically,
membranes with AgNPs displayed a decrease in microbial growth by 59–99% after this concentration
was used [63]. Silver nanoparticles incorporated into the reverse osmosis membrane with a diameter
of approximately 30 nm significantly reduced (by 64.6%) Pseudomonas sp. biofilm formation after
14 days of continuous cultivation [64]. Another study which was proposed by Saraswathi et al. [65] was
based on polydopamine-coated poly(ether imide) membranes with incorporated AgNPs. Membranes
showed antibacterial activity against both Gram-negative and Gram-positive bacteria and facilitated the
separation of toxic contaminants. In general, it can be concluded that AgNPs can be used in drinking
water treatment and as a pseudo-enzymatic catalyst in the reaction. Additionally, AgNPs-incorporated
membranes are used for wound treatment; representative examples are shown in Table 1.
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Table 1. AgNPs-membrane composites for wound treatment.
AgNPs Preparation AgNPs Size (nm) Polymer Used Incorporation Method Main Result
CHEMICAL METHOD (NaBH4) 5–14 BC BC membrane was mixed with AgNO3 and reduced with NaBH4.
Inhibition of S. aureus and E. coli growth on different sugar media (glucose,
sucrose, maltose) [66]
CHEMICAL METHOD (NaBH4) 15 Chitosan
Chitosan was mixed with AgNPs prepared by reduction of AgNO3
with NaBH4 and the mixture was left to dry.
AgNPs in chitosan wound dressing materials facilitate cell proliferation and
mitigate bacterial infection [67].
CHEMICAL METHOD (sodium citrate) 10–30 PVP chitosan
PVP and chitosan were mixed in a 1:1 ratio, then AgNPs prepared by
reduction of AgNO3 with sodium citrate were added, and afterward,
the mixture was dried for 48 h.
Addition of 0.001 to 0.01 mg AgNPs to PVP-chitosan film significantly reduced the
growth of E. coli and S. aureus [68].
CHEMICAL METHOD (sodium citrate) 5 Chitin
Chitin/nanosilver composite scaffolds were prepared by addition of
the nanosilver solution (prepared by reduction of AgNO3 with
sodium citrate) to chitin hydrogel to obtain chitin/nanosilver
composite scaffolds.
This composite inhibits the growth of S. aureus and E. coli. Inhibition zone on the
plate was higher in E. coli than S. aureus, indicating higher susceptibility of
Gram-negative bacteria to nanosilver [69].
CHEMICAL METHOD (NaBH4) 3–17 BC
AgNPs were impregnated into BC fiber by immersing BC pellicles in
AgNO3 for 1 h. The silver ion-saturated BC pellicles were reduced
with NaBH4.
The growth inhibition ring of E. coli and S. aureus was 2 and 3.5 mm, respectively.
No inhibition zone was observed with the pure BC as a control [70].
GREEN METHOD (egg white) 8–32 KGM KGM/AgNPs composite sponge
Animal models showed that the KGM/AgNPs composite sponges effectively
accelerated wound healing, fibroblast growth promotion and wound
epithelialization on the rabbit model [71].
GREEN METHOD (Camelia sinensis) 60–150 Chitosan and chitin Film casting and dipping in AgNO3 solution
Evaluation of nanofilms as a temporary biological wound dressing material for
rats had revealed good healing activity [72].
GREEN METHOD (chitosan) 16 Chitosan, PVA, CU Film casting by evaporation AgNPs prepared from chitosan demonstrated significant effects against variouscommon pathogens (E.coli, S. aureus, P. aeruginosa, C. albicans) [73].
GREEN METHOD (cellulose from A. xylinum) 50–150 BC AgNO3 and AgCl reduced by BC and directly incorporated into BC
Membranes exhibited high hydrophilic ability and strong antimicrobial activity
against S. aureus and E. coli [74].
IRRADIATION METHOD (gamma rays, 60Co) 3–13 Chitin
Gamma rays prepared AgNPs were mixed with chitin in 5% LiCl and
DMA system.
Bactericidal effect was significant (p < 0.01) in the presence of chitin nanosilver
dressings, whereas the counts of bacteria progressively increased in the absence of
nanosilver dressings [75].
THERMAL METHOD (thermal reduction; 80 ◦C) 10–30 Purchased BC Freeze-dried BC membrane impregnated with AgNPs (directincorporation)
The thermally prepared AgNPs exhibited significant antibacterial activity, with
more than 99% reduction in S. aureus. Moreover, composites allowed attachment
and growth of epidermal cells with no cytotoxicity that emerged [76].
Explanation of abbreviations: BC—bacterial cellulose; CU—curcumine; DMA—dimethylacetamide; KGM—konjac glucomannan; PVA—poly(vinylalcohol); PVP—poly(vinylpyrrolidone).
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4.1. Chemical-Synthesized AgNPs Incorporated into Membranes and Composite Materials
The bacterial cellulose (BC) membrane has been utilized as a template for the in-situ preparation
of AgNPs through the chemical reduction method. The lyophilized cellulose membrane with AgNPs
was placed on the E. coli or S. aureus grown on an agar plate and incubated at 37 ◦C for 24 h. The sample
derived from maltose with a silver content of 1.06% realized >99.99% killing ratio in the number of
viable E. coli, when cultivated on maltose after a contact period of 18 h. Therefore, 1.2 mg of the
silver-containing composite was sufficient to ensure no detectable growth of E. coli in 0.1 mL of medium
with a bacteria concentration of around 108 CFU (colony forming units)/mL [66].
Levi-Polyachenko et al. [67] prepared chitosan membrane by the solvent casting method and
loaded it with a different concentration of hexagonal AgNPs synthesized through the chemical
route to demonstrate the synergistic wound healing activity. The developed hexagonal AgNPs
represented a new addition to the chitosan wound dressing materials, as they could facilitate cell
proliferation, mitigate bacterial infection and generate mild hyperthermia for the delivery of small
drug molecules [67].
Another chemical method for the synthesis of AgNPs using AgNO3 as a precursor was reported.
The generated nanoparticles were loaded into casted poly(vinylpyrrolidone)-chitosan (PVP-chitosan)
membrane. The PVP-chitosan-silver composite film found higher antibacterial activity than both
chitosan and AgNO3 alone. The L929 cell lines were used for a cytotoxicity study and adult male albino
rats (140–180 g) were selected for the in vivo wound healing study. The prepared film exhibited higher
wound healing efficiency than the cotton gauge, 100% chitosan and other reported chitosan-based
dressings [68].
The chemical reduction of AgNO3 resulted in the formation of AgNPs, which were loaded into the
chitin hydrogel. These hydrogels were lyophilized to obtain the AgNPs-impregnated chitin membrane.
These chitin-nanosilver composite scaffolds exhibited good blood clotting ability and were also found
to be bactericidal against S. aureus and E. coli [69].
Maneerung et al. isolated BC [70] produced by Acetobacter xylinum. It was used as a template for
the synthesis of AgNPs through the chemical method. The freeze-dried silver nanoparticle-impregnated
BC exhibited strong antimicrobial activity against E. coli (Gram-negative) and S. aureus (Gram-positive)
bacteria [70].
4.2. Green-Synthesized AgNPs Incorporated into Membranes and Composite Materials
A composite sponge was made using konjac glucomannan (KGM) as the polymer and loaded
with AgNPs that were prepared through a green synthesis method using egg white as a reducing
agent. Animal models showed that the KGM-AgNPs composite sponges had effectively accelerated
the wound healing process. The histological findings showed that they promoted fibroblast growth
and accelerated epithelialization [71].
The regenerated cellulose and chitosan were blended and made into a solution for film casting in
the presence of AgNO3 as a precursor for AgNPs production through the green reduction method.
The tea grains (Camellia sinensis) were used as a reducing as well as a capping agent for the NPs.
Evaluation of the optimized composite film for temporary biological wound dressing materials on the
experimental wounds of rats had revealed the significant wound healing of the experimentally treated
wounds faster than the control wounds [72].
The solvent casting method was performed for the preparation of chitosan-polyvinyl alcohol
(PVA)-curcumin (CU) composite membrane loaded with AgNPs. The AgNO3 solution precursor was
added to the composite mixture, which led to the formation of AgNPs through the reduction of the
precursor by chitosan and PVA. The antimicrobial and antifungal activity of the chitosan-PVA-AgNPs
films demonstrated significant effects against E. coli, Pseudomonas, Staphylococcus, Micrococcus, C. albicans
and P. aeruginosa. To improve the therapeutic efficiency further, CU was encapsulated along with
chitosan-PVA-AgNPs nanocomposite films, which showed enormous growth inhibition of E. coli
compared to plain CU and chitosan-PVA-AgNPs film alone [73].
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The BC produced by Acetobacter xylinum was isolated and dipped in AgNO3 and AgCl solution
to produce AgNPs. In-situ production of NPs was performed using the membrane as a template.
The AgCl NPs-impregnated membrane exhibited high hydrophilic ability and strong antimicrobial
activity against E. coli and S. aureus [74].
4.3. Irradiation-Synthesized AgNPs Incorporated into Membranes and Composite Materials
Chitin membranes loaded with AgNPs were prepared by the solvent casting method in the
presence of 5% LiCl and dimethylacetamide (DMA) solvent system. The NPs were prepared by
the gamma irradiation method, using AgNO3 as the precursor. The chitin membranes were loaded
with ascending concentrations of AgNPs from 30 to 100 ppm. The chitin membranes with 100 ppm
AgNPs showed promising antimicrobial activity against common wound pathogens (P. aeruginosa and
S. aureus) [75].
4.4. Thermal-Synthesized AgNPs Incorporated in Membranes and Composite Materials
In-situ preparation of AgNPs inside the BC membrane by thermal reduction at 80 ◦C was
executed to obtain AgNPs-loaded BC scaffold. The results showed that AgNPs-BC exhibited significant
antibacterial activity against S. aureus. Moreover, AgNPs-BC allowed attachment and growth of rat
fibroblasts with low cytotoxicity. The fresh epidermal and dermis thicknesses of the skin treated with
AgNPs-BC samples were 111 and 855 µm, respectively, which was significantly higher than 74 and
619 µm for BC-treated groups and 57 and 473 µm for untreated control wounds [76].
5. Powdered AgNPs and Topical Application
Powdered AgNPs are used for incorporation into different types of clothing and dressings.
Representative examples are summarized in Table 2.
Table 2. Powdered AgNPs for wound treatment application.
Method of AgNPs
Preparation AgNPs Size (nm) Material Used Incorporation Method Main Result
CHEMICAL
METHOD (alkali
solution of starch)
22–24 cotton fabrics Pressure incorporation ofAgNPs to cotton fabrics
13- and 10-mm inhibition zones for S. aureus and E. coli
were obtained, when cotton fabrics with 250 ppm
AgNPs were used [77].
CHEMICAL
METHOD (NaBH4)
4–24 dressing material AgNPs-coateddressing material
AgNPs showed antimicrobial properties, reduction in
wound inflammation and modulation of fibrogenic
cytokines [78].
GREEN METHOD
(Fusarium oxysporum) 2 cotton fabrics
Incorporation to
cotton fabrics
AgNPs-impregnated fabrics showed a 99.9% reduction
of S. aureus growth [79].
GREEN METHOD
(Aspergillus niger) 200–800
AgNPs-incorporated
wound dressings
AgNPs-coated
dressing material
AgNPs synthesized from Aspergillus niger possess
effective wound healing activity when compared with
AgNO3 [80].
5.1. Chemical-Synthesized Powdered AgNPs and Topical Application
The powdered AgNPs were successfully prepared via the addition of AgNO3 to alkali dissolved
starch followed by precipitation with ethanol. AgNPs aqueous suspensions were prepared from powder
AgNPs by dispersion and dilution with water. The cotton fabrics were impregnated with AgNPs by
dipping in the solution with various concentrations. The results of potent healing using fabrics treated
with 250 ppm AgNPs were similar to the Dermazin cream. Moreover, the anti-inflammatory effect of
AgNPs was nearly equivalent to a 20-mL dose of the reference indomethacin drug [77].
The wound dressing materials coated with chemically synthesized AgNPs were tested for
their antibacterial activity. Rapid healing and improved cosmetic appearance were observed in
a dose-dependent manner. Furthermore, through quantitative PCR, immunohistochemistry and
proteomic studies, the positive effects exerted by AgNPs by their antimicrobial properties, reduction in
wound inflammation and modulation of fibrogenic cytokines were demonstrated [78].
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5.2. Green-Synthesized Powdered AgNPs and Topical Application
Duran et al. synthesized AgNPs using Fusarium oxysporum. AgNPs were loaded inside the clothes
and tested for their antibacterial activity against S. aureus. AgNPs demonstrated a 99% reduction in
bacterial counts [79].
Sundaramoorthi et al. prepared AgNPs from Aspergillus niger using AgNO3 as a precursor.
AgNPs incorporated into wound dressings had antibacterial activity and formed inhibition zones:
15 mm for S. aureus, 11 mm for B. subtilis, 10 mm for E. coli and 14 mm for P. aeruginosa [80].
6. Nanofibers
Nanofibers as materials can be used as a platform in Raman spectroscopy [81],
in immunoanalysis [82], for air filtration [83] and as a pseudo-enzyme [84]. As can be seen, the AgNPs,
besides their important wound treatment activity, which is summarized in Table 3 below, can be used
also for disinfection and catalytic purposes.
Table 3. AgNPs nanofibers for wound treatment.
Method of AgNPs
Preparation AgNPs Size (nm) Polymer Used Incorporation Method Main Result
CHEMICAL METHOD
(sodium citrate) 25–55 Collagen Electrospun fibers
Histology analysis revealed accelerated wound
healing [85].
CHEMICAL METHOD
(N,N-DMF) 3–5 PVP
Ag+ in PVP solution were reduced to
nanofibers with N,N-DMF.
AgNPs-PVP showed the ability to be used in
antibacterial separation filters [86].
CHEMICAL METHOD (Ag+
dipped in PMMDM) <20 PMMDM
Electrospun fibers were dipped in
AgNO3 solution and dried in
a vacuum.
AgNPs showed high antibacterial activity without
significant effects on mammalian cells [87].
CHEMICAL METHOD
(PBG reduction) 60 PBG
AgNO3 was reduced with PBG and
then crosslinked with collagen.
Antibacterial and pro-wound healing activities in
the PBG crosslinked collagen scaffold suggest the
importance of nanobiotechnology for the
development of biomaterials for tissue engineering
applications [88].
CHEMICAL METHOD
(AgNO3 reduced with
gelatin powder)
11–20 Gelatin fibers Electrospun fibers further crosslinkedglutaraldehyde.
High antibacterial activity in response to
Gram-positive (methicillin- resistant S. aureus) and
Gram-negative bacteria [89].
CHEMICAL METHOD
(AgNO3 reduced with PEO
and DMF)
13–17 PEOPCL Electrospun fibers Composite nanofibers possessed good roughness,wettability and antibacterial potential [90].
CHEMICAL METHOD
(NaBH4)
5–17 Alginate
AgNO3 was loaded on fibers and
afterward reduced to Ag0
with NaBH4.
The alginate fibers loaded with AgNPs reduce the
inflammatory phase and increase epidermal
thickness, improving the overall quality and speed
of healing [91].
GREEN METHOD
(chitosan, glucose) 10–30
Chitosan, glucose,
PVA
AgNPs were used for electrospinning
nanofiber materials.
The antibacterial experiment indicated that the
electrospun mats of PVA/chitosan blends had good
bactericidal activity against the Gram-negative
E. coli [92].
GREEN METHOD
(PGA, HA) 5–13 PGA
PGA was mixed with AgNO3 to
obtain AgNPs, then mixed with HA,
and the mixture was electrospun to
obtain nanofibers.
The in vivo study in albino rats showed maximum
wound epithelization and collagen deposition after
14 days of nanofiber administration [93].
GREEN METHOD
(P. nigrum) 5–20 PCL
AgNPs were mixed with PCL during
electrospinning to obtain nanofibers.
The fabricated material showed excellent
antibacterial activity against both S. aureus and E.
coli, which suggests the ability of the fabricated
material to prevent bacterial colonization in
wounds covered with this material [94].
IRRADIATION METHOD
(gamma rays, 60Co) 23–24 PVA
AgNO3, PVA and ethanol were
mixed, nitrogen-flushed and radiated
by 60Co.
The manufacture and evaluation of silk-based
wound dressings in this study showed that the
incorporation of AgNPs at low concentrations on
electrospun SF mats could confer significant
antibacterial activity against S. aureus and
P. aeruginosa [95].
Explanation of abbreviations: DMF—dimethylformamide; HA—hyaluronic acid; PBG—plumbagine;
PCL—poly(caprolactone); PEO—poly(ethylene oxide); PEOPCL—poly(ethylene oxide)-poly(caprolactone);
PGA—polygalacturonic acid; PMMDM—poly(methyl methacrylate-co-dopamine methacrylamide);
PVA—poly(vinylalcohol); PVP—poly(vinylpyrrolidone);SF—silk fibroin
6.1. Chemical Synthesis of AgNP-Containing Nanofibers
The chemically synthesized AgNPs were added to the electrospinning solution containing collagen
to obtain the nanofibers. The in-vivo study proved that the rate of wound healing of the composite
nanofiber mats was accelerated compared with plain collagen nanofibers. Histology analysis revealed
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accelerated re-epithelization, collagen production and better wound contraction with AgNPs composite
collagen nanofibers [85].
The PVP nanofibers loaded with AgNPs that were reduced from precursor by
N,N-dimethylformamide (DMF) were reported. The PVP-containing AgNPs could be used to introduce
the nanoparticles into any other polymer nanofibers that are miscible with PVP. The PVA nanofiber
mats were strong enough to act as antimicrobial separation filters [86].
An electrospun fiber made of poly(methyl methacrylate-co-dopamine methacrylamide) (PMMDM)
was dipped into the AgNO3 solution for on-surface synthesis of AgNPs. The PMMDM-AgNP composite
nanofibers containing 1% NPs achieved desirable antibacterial activity against both Gram-negative and
Gram-positive bacteria, while not significantly affecting the viability of mammalian cells. The product
was also observed with a rapid release of the AgNPs within 24 h, followed by a sustained release for
5 days thereafter [87].
The collagen fibrils were isolated from the tendons of Wistar rats and allowed to crosslink
with plumbagin (PBG)-caged AgNPs that were prepared using the chemical oxido-reduction method,
using PBG and AgNO3 as precursors. Crosslinking of collagen with PBG resulted in a uniform alignment
of collagen fibrils to form orderly aligned porous structured scaffolds with potent antibacterial activity
and enhanced ability to promote cell proliferation and wound healing [88].
The gelatin nanofibers prepared by the electrospinning technique were incorporated with AgNPs
that were prepared in-situ by the chemical reduction method. The fibers were further crosslinked with
glutaraldehyde to enhance mechanical stability. The antibacterial activity of the fibers was greatest
against P. aeruginosa, S. aureus, E. coli and methicillin-resistant S. aureus [89].
The electrospun nanofibers of poly(ethylene oxide)-poly(caprolactone) (PEOPCL) blend were
prepared in dimethylformamide solvent. The precursor AgNO3 was added to the electrospinning
solution, which was chemically reduced by DMF and poly(ethylene oxide) (PEO). In addition, the PEO
acted as a stabilizer for the formation of NPs. The composite nanofibers possessed antibacterial
potential against antibiotic-resistant E. coli [90].
A wet spinning technique was carried out in the CaCl2 precipitation bath for the preparation
of alginate fibers. The chemically reduced AgNPs solution was mixed with a spinning solution,
which resulted in AgNPs-incorporated alginate fibers. AgNPs-loaded fibers could be easily applied in a
wound healing paradigm, which could promote the repair process through the promotion of fibroblast
migration to the wound area, reduction of the inflammatory phase and an increase in epidermal
thickness in the repaired wound area, thereby improving the overall quality and speed of healing [91].
6.2. Green Synthesis of AgNPs-Containing Nanofibers
A green method for the synthesis of AgNPs was reported through the electrospinning technique
in the presence of chitosan as a reducing agent along with PVA to obtain nanofibers. The results
showed the superior qualities of the fibers and synergistic antibacterial effects by the combination of
chitosan with AgNPs [92].
Very recently, El-Aassar et al. published a methodology to obtain silver-containing nanofibers
by using polygalacturonic and hyaluronic acid. Successful AgNPs synthesis by PGA was verified by
UV-vis spectral maxima ranging between 410 and 415 nm and a transmission electron microscopy
image of 8.6 nm average particulate diameter. AgNPs components of (Ag-PGA/HA)-PVA nanofiber
exhibited robust zone inhibition antibacterial activity against both Gram-positive and Gram-negative
bacteria [93].
Another green synthesis method was also reported for developing AgNPs using P. nigrum leaf
extract. The NPs solution was mixed with polycaprolactone (PCL) solution during electrospinning
to obtain the nanofibers. The fabricated material showed excellent antibacterial activity against both
S. aureus and E. coli, which also confirmed the ability to prevent bacterial colonization in wounds
covered with this composed material [94].
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6.3. Irradiation Synthesis of Silver Nanofibers
Nanofibers of silk fibroin were prepared using an electrospinning technique and loaded with
AgNPs synthesized from the AgNO3 precursor using the gamma irradiation method. AgNPs-coated
nanofibers effectively inhibited the growth of S. aureus and P. aeruginosa when the coating solution
containing colloidal AgNPs was 4 mM or equivalent to 50.4 ng/cm2 of adsorbed AgNPs [95].
7. AgNPs-Hydrogels
AgNPs incorporated in poly(N-iospropylacryamide-co-acrylamido-2-methylpropane sulfonic
acid) (NIPAMSA) cryogel were used for the reduction of 4-nitrophenol to 4-aminophenol [59].
AgNPs/starch/PEG/PAA hydrogel was created by Saberi et al. for Hg2+ removal. The maximum
adsorption capacity of Hg2+ ions for hydrogel was found to be 158.21 mg/g and 182.53 mg/g in pH 7
and 6 in aqueous solutions, respectively [96]. Similarly, Dil and Sadeghi created nanosilver/gelatin/PAA
hydrogel for Cu2+ removal. The absorption capacity was 147.10 mg/g in pH 5.5 for 40 min, measured
with the atomic absorption spectroscopy technique [97]. As seen, AgNPs-hydrogels, besides their
wound applications, are used for metal removal and catalytic activity. Their usage for wound treatment
is shown in Table 4.
Table 4. AgNPs hydrogels for wound treatment.
Method of AgNPs
Preparation AgNPs Size (nm) Polymer Used Incorporation Method Summary
CHEMICAL METHOD
(NaBH4)
2–3 PAA and PVA
Hydrogels were soaked in AgNO3
solution to absorb Ag+ and afterward
reduced with NaBH4.
Hydrogel alone exhibited no antibacterial activity;
however, Ag+-hydrogels and AgNPs-hydrogels
showed significant antibacterial activity against
E. coli [98].
CHEMICAL METHOD
(sodium citrate) 4–8 β-chitin
β-chitin/nanosilver composite
scaffolds were prepared by adding
nanosilver to β-chitin hydrogel and
stirring well for 15 min.
The composite scaffold showed inhibitory effects
on bacterial growth, signifying its role as an
antibacterial agent. Cytotoxicity studies on the
vero cell line proved that the composite scaffold
was non-toxic [99].
GREEN METHOD (sericin
and chitosan) 240–970 Chitosan
The chitosan-sericin solution was
mixed with AgNO3
Hydrogel (S/C-SNPs G-1) demonstrated
bactericidal activity [100].
IRRADIATION METHOD
(UV radiation) Not given AMSAS
AgNO3 was added to AMSAS
solution, with MBA as a crosslinker.
The novel silver hydrogel is an effective
antimicrobial dressing and these results support
the possibility of using the novel silver hydrogel as
a burn wound dressing [101].
IRRADIATION METHOD
(UV radiation, gamma
rays 60Co)
90 PVA
The mixed solution of AgNO3 and
PVA was UV-radiated, dried and
gamma rays radiated.
Samples containing AgNPs showed antimicrobial
activity against E. coli, S. aureus and C. albicans. No
sample was toxic to mouse fibroblasts [102].
THERMAL METHOD
(reduction at 40 ◦C) 5–14 Collagen
AgNO3 was mixed with gelatin
powder and the mixture was reduced
at 40 ◦C.
Hydrogels inhibited at least 99.8% of the bacterial
growth against E. coli, S. aureus and
P. aeruginosa [103].
THERMAL METHOD
(reduction at 70—100 ◦C). 7–21 CMC
AgNO3 was mixed with PEG and
CMC and reduced at 70–100 ◦C.
The absorbing property of SNP-CMC gel would
help in removing the exudates and preventing
wound maceration, while the donation property
would help in debridement of dead tissue.
These properties facilitate early wound
healing [104].
Explanation of abbreviations: AMSAS—2-acrylamido-2-methylpropane sulfonic acid sodium salt;
CMC—carboxymethylcellulose; MBA—N,N′-methylenebis(acrylamide); PAA—poly(acrylic acid);
PEG—poly(ethylene glycol); PVA—poly(vinylalcohol); SNP—silver nanoparticles.
7.1. Chemical Synthesis of AgNPs-Containing Hydrogels
The hydrogel made of polyacrylamide/poly(vinyl alcohol) was used as a template to produce
AgNPs through the chemical route. The engineered hydrogel-AgNPs exhibit higher activity on E. coli
compared to AgNPs alone [98].
Using β-chitin as the starting material, the hydrogel was prepared and loaded with chemically
synthesized AgNPs. The prepared β-chitin/nanosilver composite scaffolds exhibited significant
bactericidal activity against E. coli and S. aureus and showed good blood-clotting ability. Cell attachment
studies using vero (epithelial) cells showed better adherence of the cells on the scaffolds [99].
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7.2. Green Synthesis of AgNPs-Containing Hydrogels
A hydrogel made of carbopol was loaded with in-situ prepared AgNPs, using sericin and chitosan
as capping and reducing agents, respectively. The antimicrobial activity and wound healing activity of
the optimized hydrogel demonstrated higher bactericidal activity and wound closure, as supported by
results of histopathology [100].
7.3. Irradiation Synthesis of AgNPs-Containing Hydrogels
A novel wound dressing material was prepared using 2-acrylamido-2-methylpropane sulfonic
acid sodium salt (AMSAS) hydrogel loaded with AgNPs. The silver nitrate solution was added to
the AMSAS solution and the NPs synthesis was initiated through gamma irradiation. This novel
silver hydrogel showed excellent antimicrobial activity. A hydrogel made of AMSAS was prepared
and loaded with AgNO3 solution and the reaction mixture was irradiated with UV radiation for the
formation of AgNPs. The antibacterial activity of the hydrogels against common burn pathogens
was studied and the results showed that 5 mM AgNPs-loaded hydrogel had the greatest inhibitory
activity [101].
The PVA solution mixed with the AgNO3 solution was gamma-irradiated for the reduction
process of the precursor and then made into hydrogels. The hydrogels were dried in vacuum at
40 ◦C. PVA-Ag samples were non-toxic and presented antimicrobial activity, confirming that 0.25%
AgNO3 concentration was enough to establish a potential antimicrobial effect. The samples also
presented suitable mechanical and swelling properties in all media, representative for potential burn
site applications [102].
7.4. Thermal Synthesis of AgNPs-Containing Hydrogels
Gelatin solution was mixed with the AgNO3 solution, wherein the precursor was reduced at 40 ◦C.
Furthermore, hydrogels were prepared from the same, which were effective against S. aureus, E. coli
and P. aeruginosa, with at least 99.7% bacterial growth inhibition. The hydrogels containing AgNO3 at
0.75 and 1.0 wt% were not detrimental to the skin cells that had been cultured directly on them [103].
The in-situ preparation of AgNPs inside carboxymethylcellulose (CMC) gel was carried out.
The antimicrobial activity studies showed that CMC-SNP containing 50 ppm of AgNPs was effective
against the growth of both Gram-negative and Gram-positive strains including methicillin-resistant
S. aureus. These results indicated that the reported nanoparticles could be an ideal option for the
treatment of deep infected wounds [104].
In total, 28 publications with mention of the tested microorganisms (Table 5) were searched to
determine which bacteria and fungi are used for testing materials for wound dressings (publications
from Table 1, Table 2, Table 3, Table 4 were used, except [67,72,78,86,105], where no microorganisms but
eukaryotic cells were tested). As seen in Table 5, S. aureus is the most favored model as a Gram-positive
bacterium because it is a high-priority pathogen [106]. Very favored models for wound testing are also
Gram-positive E. coli and P. aeruginosa. Besides bacteria, fungi models are also tested (C. albicans).
Table 5. Frequency of tested bacteria and fungi for wound treatment.
Cell Species AA RA (%) References
S. aureus * 24 85.7 [66,68–71,73–77,79,80,85,87,89,92–94,99–104]
E. coli 22 78.6 [66,68–71,73,74,76,77,79,80,87–90,93,94,98,99,102–104]
Micrococcus 1 3.6 [73]
P. aeruginosa 9 32.1 [73,75,76,80,85,87,89,101,103]
C. albicans 4 14.3 [73,77,101,102]
Enterococcus 1 3.6 [101]
B. subtilis 3 10.7 [80,88,93]
A. baumannii 1 3.6 [101]
* including methicillin-resistant S. aureus, AA—absolute abundance, RA—relative abundance.
Pharmaceutics 2020, 12, 821 16 of 24
8. Safety of AgNPs in Wound Dressing Applications
The question of the potential toxicity of AgNPs is widely discussed. Nanomaterials can easily
pass through cell membranes and adversely affect human health [107]. In mouse models, they passed
through the blood–brain and blood–testis barriers [108]. AgNPs in higher concentrations (>44.0 µg/mL)
are necrotic to cells, resulting in cell membrane rupture [107]. After their passing through the
blood–testis barrier, AgNPs are deposited in the testes and can have adverse effects on sperm
cells [109]. They have also been shown to damage other cells such as the brain [110], liver [111]
and stem cells [112]. However, the findings of many authors indicated that the use of AgNPs as a
topical antibacterial agent is safe. The AgNPs-loaded hydrogel is considered an excellent wound
dressing [113]. If used in reasonable quantities, silver metal and silver dressings have no negative
effects on human health [114,115]. For example, Kokura et al. [116] studied the permeability of
AgNPs in human skin and their cytotoxicity in human HaCaT (a spontaneously immortalized human
keratinocyte line) keratinocytes under ultraviolet B (UVB) irradiation. Based on a transcutaneous
passage assay using human skin, AgNPs did not penetrate healthy intact human skin. AgNPs showed
no effect on keratinocytes and did not increase UVB-induced cell death. The efficacy of AgNPs
increases at low concentrations. AgNPs do not easily penetrate the skin barrier and have no detrimental
effects on keratinocytes [116]. Thus, AgNPs possess the outstanding potential for use in wound
dressing applications.
In addition, NPs are generally considered a promising replacement for antibiotics due to
their bactericidal activity against a large number of pathogens and the non-induction of microbial
resistance [117]. AgNPs, in particular, have received a great deal of attention from scientists due to their
inhibitory effect on around 650 microbe species and antibiotic-resistant bacteria [118]. AgNPs inhibit
bacterial reproduction by denaturing bacterial DNA, leading to the alteration and subsequently
the death of the bacterial cell [119]. Moreover, AgNPs can be an appropriate therapeutic agent or
prophylactic because they prevent the colonization of the wound by antibiotic-resistant bacteria
and other microbes that impede wound healing [120]. Based on using human keratinocytes and
dermal fibroblasts, AgNPs significantly reduced levels of inflammatory cytokines and promoted
healing [121]. In vitro cell culture tests exhibited no cytotoxicity in the hydrogel containing AgNPs
and non-adherent character to dermal fibroblasts [122]. Compared with conventional topical agents,
AgNPs can both effectively prevent wound infections and improve the healing process of injured
tissues. AgNPs-coated wound dressings possess considerable antibacterial activity and repair tissues
faster and more efficiently [123]. Application of silver modified nanoporous silica carriers loaded
with sulfadiazine instead of silver sulfadiazine could overcome the poor aqueous solubility of silver
sulfadiazine which limits its antibacterial effect [124].
On the contrary, some authors are convinced of the risks of using AgNPs. Some cases where
argyria appeared after treatment of burn wounds with dressings containing nanocrystalline silver were
reported [125,126]. The use of these dressings caused the deposition of the silver particles into the mid
and deep dermis [125]. For silver itself, it was found that this metal had a concentration-dependent
cytotoxic effect on human dermal fibroblast cells [127]. However, thanks to the development of
nanotechnology, its minimum inhibitory concentration, as well as toxicity to normal human cells,
was reduced [128] and a number of brands of wound dressings containing silver have been accepted
by the U.S. Food and Drug Administration [100]. On the other hand, Burd et al. [129] demonstrated
that some commercial silver-based dressings exhibited cytotoxic effects on cultured keratinocytes
and fibroblasts.
9. Conclusions
Nanomaterials nowadays represent a very promising way to eliminate bacterial, fungal and
viral infections. Besides their antibiotic, antifungal and antiviral effects, they are used as catalysts,
bioremediation elements and pseudo-enzymes. This review represents successful results of the
nanotechnology field in the very last years. Acute and chronic wounds are problematic to heal and are
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often underestimated by people. The types of treatment were divided based on article information
into four categories: membranes, powdered, nanofibers and hydrogels, prepared by different types of
synthesis. It can be concluded that the chemical method of synthesizing NPs can obtain NPs with
uniformity and reproducibility of preparation. However, a growing supply of lowering of environment
pollution is not in consensus with the use of this type of synthesis. Green synthesis is much more
environmentally and user friendly because it uses a natural source of reduction agents. A wide spectrum
of different types of NPs can be obtained. It is necessary to mention that optimization of the production
of uniform green-synthesized NPs can take a long time because slight, unwitting changes in laboratory
protocol can lead to the production of NPs with completely different chemical and physical properties.
Furthermore, the detailed characterization of an extract of plant or fungus is needed. Irradiation
synthesis of nanoparticles shows an interesting way to produce unique, unrepeatable NPs, which can be
considered as the main advantage. The main disadvantages are the complicated legislature connected
with work with radiation sources and increase the risk of harm to health. Thermal synthesis is based
on artificial or natural chemicals as reducing agents connected with increased temperature. In its
essence, it is a combination of green and chemical synthesis methods, where the higher temperature
is the main element of reduction power. Potential advantages and disadvantages ensue from other
components used in thermal synthesis. Despite a plethora of different publications in recent years,
it is still necessary to find new polymers and new types of synthesis of (not only) AgNPs, because of
the growing bacterial resistance to metal NPs. It is important mainly not to forget to conduct valid
tests on eukaryotic cells to determine how to achieve the best effect against prokaryotic cells and at the
same time ensure no harmful effect against eukaryotic cells. Suitable models can be keratinocytes and
fibroblasts, which are also mentioned as models in this publication.
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Abbreviations
AgNPs silver nanoparticles
AMSAS 2-acrylamido-2-methylpropane sulfonic acid sodium salt
BC bacterial cellulose
CMC carboxymethylcellulose
CU curcumine
DMA dimethylacetamide
DMF dimethylformamide
GO graphene oxide
HA hyaluronic acid
Pharmaceutics 2020, 12, 821 18 of 24
HaCaT the immortal human keratinocyte line
IPA isopropanol
KGM konjac glucomannan
MBA N,N′-methylenebis(acrylamide)
NIPAMSA poly(N-isopropylacryamide-co-2-acrylamido-2-methylpropane sulfonic acid)
NPs nanoparticles
PAA poly(acrylic acid)
PBG plumbagine
PCL poly(caprolactone)
PDMS poly(dimethylsiloxane)
PEG poly(ethylene glycol)
PEO poly(ethylene oxide)
PEOPCL poly(ethylene oxide)-poly(caprolactone)
PGA polygalacturonic acid
PMMDM poly(methyl methacrylate-co-dopamine methacrylamide)
PVA poly(vinylalcohol)
PVP poly(vinylpyrrolidone)
SF silk fibroin
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